CHEBI:229764 - selinexor

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name selinexor
ChEBI ID CHEBI:229764
Definition A member of the class of triazoles that is 1H-1,2,4-triazole substituted by (1Z)-3-oxo-3-[2-(pyrazin-2-yl)hydrazinyl]prop-1-en-1-yl and 3,5-bis(trifluoromethyl)phenyl groups at positions 1 and 3, respectively. It is a prescription medicine approved for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C17H11F6N7O
Net Charge 0
Average Mass 443.313
Monoisotopic Mass 443.09293
InChI InChI=1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1-
InChIKey DEVSOMFAQLZNKR-RJRFIUFISA-N
SMILES FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F
Roles Classification
Biological Role(s): exportin 1 inhibitor
Any inhibitor of exportin 1.
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing selinexor (CHEBI:229764) has role anti-inflammatory agent (CHEBI:67079)
selinexor (CHEBI:229764) has role antineoplastic agent (CHEBI:35610)
selinexor (CHEBI:229764) has role apoptosis inducer (CHEBI:68495)
selinexor (CHEBI:229764) has role exportin 1 inhibitor (CHEBI:229763)
selinexor (CHEBI:229764) is a (trifluoromethyl)benzenes (CHEBI:83565)
selinexor (CHEBI:229764) is a enamide (CHEBI:51751)
selinexor (CHEBI:229764) is a hydrazide (CHEBI:35362)
selinexor (CHEBI:229764) is a pyrazines (CHEBI:38314)
selinexor (CHEBI:229764) is a triazoles (CHEBI:35727)
IUPAC Name
(2Z)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}-N'-(pyrazin-2-yl)prop-2-enehydrazide
INNs Sources
selinexor WHO MedNet
selinexor WHO MedNet
sélinexor WHO MedNet
selinexorum WHO MedNet
Synonyms Sources
(2Z)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1- yl}-N'-(pyrazin-2-yl)prop-2-enehydrazide ChEBI
KPT 330 DrugBank
KPT-330 DrugBank
Brand Name Source
Xpovio KEGG DRUG
Manual Xrefs Databases
D11222 KEGG DRUG
DB11942 DrugBank
HMDB0258217 HMDB
Selinexor Wikipedia
View more database links
Citations Waiting for Citations Types Sources
23373539 PubMed citation Europe PMC
27893412 PubMed citation Europe PMC
28314790 PubMed citation Europe PMC
28810913 PubMed citation Europe PMC
28852098 PubMed citation Europe PMC
29707241 PubMed citation Europe PMC
30064906 PubMed citation Europe PMC
30115935 PubMed citation Europe PMC
30996012 PubMed citation Europe PMC
32598257 PubMed citation Europe PMC
33403670 PubMed citation Europe PMC
33507295 PubMed citation Europe PMC
33601919 PubMed citation Europe PMC
34488662 PubMed citation Europe PMC
34669417 PubMed citation Europe PMC
34741230 PubMed citation Europe PMC
35355406 PubMed citation Europe PMC
35477814 PubMed citation Europe PMC
35667526 PubMed citation Europe PMC
35941226 PubMed citation Europe PMC
36180918 PubMed citation Europe PMC
36200270 PubMed citation Europe PMC
36622814 PubMed citation Europe PMC
36731340 PubMed citation Europe PMC
36827679 PubMed citation Europe PMC
36847599 PubMed citation Europe PMC
37016732 PubMed citation Europe PMC
37046649 PubMed citation Europe PMC
37047788 PubMed citation Europe PMC
37079389 PubMed citation Europe PMC
37094850 PubMed citation Europe PMC
37126200 PubMed citation Europe PMC
37175668 PubMed citation Europe PMC
37184196 PubMed citation Europe PMC
37191210 PubMed citation Europe PMC
37346402 PubMed citation Europe PMC
37595020 PubMed citation Europe PMC
37715291 PubMed citation Europe PMC
37760508 PubMed citation Europe PMC
37945593 PubMed citation Europe PMC
38105606 PubMed citation Europe PMC
38186637 PubMed citation Europe PMC
38454813 PubMed citation Europe PMC
Last Modified
13 March 2024